BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28230291)

  • 21. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells.
    Nakamura K; Martin KC; Jackson JK; Beppu K; Woo CW; Thiele CJ
    Cancer Res; 2006 Apr; 66(8):4249-55. PubMed ID: 16618748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting BDNF/TrkB pathways for preventing or suppressing epilepsy.
    Lin TW; Harward SC; Huang YZ; McNamara JO
    Neuropharmacology; 2020 May; 167():107734. PubMed ID: 31377199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
    Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
    Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancer.
    Mazouffre C; Geyl S; Perraud A; Blondy S; Jauberteau MO; Mathonnet M; Verdier M
    J Cell Mol Med; 2017 Oct; 21(10):2610-2622. PubMed ID: 28597984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of hydatidiform molar growth by inhibiting endogenous brain-derived neurotrophic factor/tyrosine kinase B signaling.
    Kawamura K; Kawamura N; Kawagoe Y; Kumagai J; Fujimoto T; Terada Y
    Endocrinology; 2012 Aug; 153(8):3972-81. PubMed ID: 22719055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer.
    Akil H; Perraud A; Jauberteau MO; Mathonnet M
    World J Gastroenterol; 2016 Jan; 22(2):490-500. PubMed ID: 26811602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental Enrichment Reverses Tyrosine Kinase Inhibitor-Mediated Impairment Through BDNF-TrkB Pathway.
    Bengoetxea H; Rico-Barrio I; Ortuzar N; Murueta-Goyena A; Lafuente JV
    Mol Neurobiol; 2018 Jan; 55(1):43-59. PubMed ID: 28842826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HO-1 attenuates hippocampal neurons injury via the activation of BDNF-TrkB-PI3K/Akt signaling pathway in stroke.
    Qi D; Ouyang C; Wang Y; Zhang S; Ma X; Song Y; Yu H; Tang J; Fu W; Sheng L; Yang L; Wang M; Zhang W; Miao L; Li T; Huang X; Dong H
    Brain Res; 2014 Aug; 1577():69-76. PubMed ID: 24997248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BDNF-TrkB pathway mediates neuroprotection of hydrogen sulfide against formaldehyde-induced toxicity to PC12 cells.
    Jiang JM; Zhou CF; Gao SL; Tian Y; Wang CY; Wang L; Gu HF; Tang XQ
    PLoS One; 2015; 10(3):e0119478. PubMed ID: 25749582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trk inhibitor attenuates the BDNF/TrkB-induced protection of neuroblastoma cells from etoposide in vitro and in vivo.
    Li Z; Zhang Y; Tong Y; Tong J; Thiele CJ
    Cancer Biol Ther; 2015; 16(3):477-83. PubMed ID: 25700942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TrkB is involved in the mechanism by which BDNF accelerates the glutamate-induced death of rat neuroblastoma B35 cells.
    Maki T; Arishima K; Yamamoto M; Sakaue M
    Neurol Res; 2015 Jan; 37(1):30-4. PubMed ID: 24934279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer.
    Kimura S; Harada T; Ijichi K; Tanaka K; Liu R; Shibahara D; Kawano Y; Otsubo K; Yoneshima Y; Iwama E; Nakanishi Y; Okamoto I
    Lung Cancer; 2018 Jun; 120():98-107. PubMed ID: 29748024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal obesity alters brain derived neurotrophic factor (BDNF) signaling in the placenta in a sexually dimorphic manner.
    Prince CS; Maloyan A; Myatt L
    Placenta; 2017 Jan; 49():55-63. PubMed ID: 28012455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute and chronic interference with BDNF/TrkB-signaling impair LTP selectively at mossy fiber synapses in the CA3 region of mouse hippocampus.
    Schildt S; Endres T; Lessmann V; Edelmann E
    Neuropharmacology; 2013 Aug; 71():247-54. PubMed ID: 23587649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
    Li Z; Jaboin J; Dennis PA; Thiele CJ
    Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases.
    Choy C; Ansari KI; Neman J; Hsu S; Duenas MJ; Li H; Vaidehi N; Jandial R
    Breast Cancer Res; 2017 Apr; 19(1):51. PubMed ID: 28446206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antidepressant-like effects of biperiden may involve BDNF/TrkB signaling-mediated BICC1 expression in the hippocampus and prefrontal cortex of mice.
    Zhou D; Zhang Z; Liu L; Li C; Li M; Yu H; Cai X; Sun X; Shen X; Wang J; Geng J; Wang C; Shi Y
    Pharmacol Biochem Behav; 2017 Jun; 157():47-57. PubMed ID: 28216067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perfluoroalkyl Substance Exposure and the BDNF Pathway in the Placental Trophoblast.
    Marchese MJ; Li S; Liu B; Zhang JJ; Feng L
    Front Endocrinol (Lausanne); 2021; 12():694885. PubMed ID: 34394001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain-Derived Neurotrophic Factor Induces Cell Survival and the Migration of Murine Adult Hippocampal Precursor Cells During Differentiation In Vitro.
    Ortiz-López L; Vega-Rivera NM; Babu H; Ramírez-Rodríguez GB
    Neurotox Res; 2017 Jan; 31(1):122-135. PubMed ID: 27663583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor.
    Cazorla M; Arrang JM; Prémont J
    Br J Pharmacol; 2011 Feb; 162(4):947-60. PubMed ID: 21039416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.